Medi­cal Device Soft­ware: What Plat­form Ope­ra­tors Must Know to Stay Compliant

Apps that are con­side­red medi­cal devices are sub­ject to strict regu­la­ti­ons in the EU – and app plat­forms are also respon­si­ble. Our FAQ explains the most important aspects of the MDCG Gui­dance Docu­ment 2025-04 of the EU Medi­cal Device Coor­di­na­ti­on Group

What is an MDSW app and why is its secu­ri­ty important?

A medi­cal device soft­ware app (MDSW app) is soft­ware that is used for medi­cal pur­po­ses – for exam­p­le to dia­gno­se or con­trol the­ra­pies. It can be used direct­ly by pati­ents. Its safe­ty is cru­cial as it can have a direct impact on health. MDSW apps must the­r­e­fo­re com­ply with strict EU requi­re­ments (in par­ti­cu­lar MDR (EU 2017/745) and IVDR (EU 2017/746)).

What role do app plat­form pro­vi­ders play in MDSW apps?

App plat­forms can sim­ply pro­vi­de MDSW (e.g. as hos­ting ser­vices) or actively dis­tri­bu­te them. In the first case, they are con­side­red inter­me­dia­ries and are pri­ma­ri­ly sub­ject to the Digi­tal Ser­vices Act (DSA, EU 2022/2065). Howe­ver, if they assu­me owner­ship or dis­tri­bu­ti­on of the app, they are con­side­red dis­tri­bu­tors or importers and must com­ply with the requi­re­ments of the MDR/IVDR.

What legal requi­re­ments app­ly to MDSW apps in the EU?

Main­ly the MDR (EU 2017/745) and IVDR (EU 2017/746) app­ly. In addi­ti­on, the DSA (EU 2022/2065) appli­es to plat­form pro­vi­ders. All legal requi­re­ments must be met befo­re an MDSW app can be offe­red in the EU.

What obli­ga­ti­ons do plat­forms have as intermediaries?

As inter­me­dia­ries under the DSA, plat­forms must, among other things:

  • offer mecha­nisms for report­ing ille­gal content,
  • Enable trans­pa­ren­cy of pro­duct information,
  • very lar­ge plat­forms (VLOPs) must car­ry out addi­tio­nal risk analyses.

When are plat­form pro­vi­ders con­side­red dis­tri­bu­tors or importers?

If they actively dis­tri­bu­te MDSW apps or assu­me owner­ship rights, they are con­side­red eco­no­mic ope­ra­tors and must com­ply with all MDR/IVDR requi­re­ments – e.g. on pro­duct safe­ty and coope­ra­ti­on with authorities.

What infor­ma­ti­on must manu­fac­tu­r­ers provide?

MDSW manu­fac­tu­r­ers must pro­vi­de clear infor­ma­ti­on accor­ding to MDR/IVDR, e.g:

  • Cont­act and manu­fac­tu­rer information,
  • Pro­duct details (name, UDI, purpose),
  • Safe­ty and ope­ra­ting instructions.

Why is app cate­go­riza­ti­on important?

So that users can distin­gu­ish bet­ween genui­ne medi­cal device apps and gene­ral health apps. Only apps with MDR/IVDR con­for­mi­ty may be labe­led as “medi­cal devices”.

What addi­tio­nal inspec­tion obli­ga­ti­ons do plat­forms have?

Plat­form pro­vi­ders must also com­ply with the DAS:

  • Check dea­ler infor­ma­ti­on befo­re activating,
  • Ran­dom­ly check pro­ducts for legality,
  • ana­ly­ze and miti­ga­te sys­te­mic risks annu­al­ly for very lar­ge platforms.

What to do now?

  1. Iden­ti­fy MDSW: Check whe­ther your app is clas­si­fied as a medi­cal device.
  2. Ensu­re legal com­pli­ance: Ensu­re that all requi­red pro­duct infor­ma­ti­on, labe­l­ing and evi­dence is available.
  3. Cla­ri­fy roles: Check whe­ther your plat­form is acting as an inter­me­dia­ry, dis­tri­bu­tor or importer – and ful­fill the cor­re­spon­ding obligations.
  4. Crea­te trans­pa­ren­cy: Design your plat­form so that users can cle­ar­ly reco­gni­ze rele­vant infor­ma­ti­on about MDSW apps.
  5. Estab­lish risk assess­ment and moni­to­ring: Lar­ge plat­forms in par­ti­cu­lar should intro­du­ce and docu­ment pro­ces­ses for risk assess­ment and mitigation.

Now is the right time to clo­se regu­la­to­ry gaps – befo­re super­vi­so­ry aut­ho­ri­ties beco­me acti­ve. We are hap­py to pro­vi­de support.

back

Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.